O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis

Y Gao; X Wu; J Zhu; R Yin; J Yang; J Liu; J Wang; L Wu; Z Liu; D Wang; G Lou; H Yang; Q Zhou; B Kong; Y Huang; L Chen; G Li; R An; T Tan; J Dong

doi:10.1136/ijgc-2021-IGCS.17

Article info

Oral Abstracts

Plenary 6

O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis

Free

Authors

Y Gao Peking University Cancer Hospital and Institute, Department of Gynecology, Beijing, China PubMed articles Google scholar articles
X Wu Fudan University Shanghai Cancer Center, Department of Gynecologic Oncology, Shanghai, China PubMed articles Google scholar articles
J Zhu Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Department of Gynecologic Oncology, Hangzhou, China PubMed articles Google scholar articles
R Yin West China Second University Hospital, Sichuan University, Department of Obstetrics and Gynecology; Key Laboratory of Birth Defects and Related Diseases of Women and Children (sichuan University), Ministry of Education, Chengdu, China PubMed articles Google scholar articles
J Yang Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Gynecologic Oncology, Beijing, China PubMed articles Google scholar articles
J Liu Sun Yat-sen University Cancer Center, Department of Gynecologic Oncology, Guangzhou, China PubMed articles Google scholar articles
J Wang Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Department of Gynecologic Oncology, Changsha, China PubMed articles Google scholar articles
L Wu National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Gynecologic Oncology, Beijing, China PubMed articles Google scholar articles
Z Liu The First Hospital of Jilin University, Department of Oncology, Changchun, China PubMed articles Google scholar articles
D Wang Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Department of Gynecology, Shenyang, China PubMed articles Google scholar articles
G Lou Harbin Medical University Cancer Hospital, Department of Gynecology, Harbin, China PubMed articles Google scholar articles
H Yang The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Department of Gynecologic Oncology, Kunming, China PubMed articles Google scholar articles
Q Zhou Chongqing University Cancer Hospital, Gynecological Oncology Center, Chongqing, China PubMed articles Google scholar articles
B Kong Qilu Hospital of Shandong University, Department of Obstetrics and Gynecology, Jinan, China PubMed articles Google scholar articles
Y Huang Hubei Cancer Hospital, Department of Gynecologic Oncology, Wuhan, China PubMed articles Google scholar articles
L Chen Affiliated Cancer Hospital of Guangzhou Medical University, Department of Gynecological Oncology, Guangzhou, China PubMed articles Google scholar articles
G Li Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Cancer Center, Wuhan, China PubMed articles Google scholar articles
R An The First Affiliated Hospital of Xi’an Jiaotong University, Department of Obstetrics and Gynecology, Xi’an, China PubMed articles Google scholar articles
T Tan Zai Lab (Shanghai) Co., Ltd, Randd Department, Shanghai, China PubMed articles Google scholar articles
J Dong Zai Lab (Shanghai) Co., Ltd, Randd Department, Shanghai, China PubMed articles Google scholar articles

Citation

Gao Y, Wu X, Zhu J, et al

O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis

International Journal of Gynecologic Cancer 2021;31:A10-A11.

Publication history

First published November 1, 2021.

Online issue publication

January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password